Providence Health & Services
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1859-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.providence.org
Prevalence, Awareness and Management of Hypertension in Acute Care Personnel
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-08-02
- Last Posted Date
- 2020-03-10
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 160
- Registration Number
- NCT01655654
- Locations
- 🇺🇸
Providence St. Peter Hospital, Olympia, Washington, United States
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
- First Posted Date
- 2012-07-19
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 30
- Registration Number
- NCT01644968
- Locations
- 🇺🇸
Providence Cancer Center, Portland, Oregon, United States
Multi-Drug Desensitization Protocol for Heart Transplant Candidates
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2018-06-15
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 2
- Registration Number
- NCT01556347
- Locations
- 🇺🇸
Providence Sacred Heart Medical Center, Spokane, Washington, United States
Study of Immune Responses in Patients With Metastatic Melanoma
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2013-03-07
- Lead Sponsor
- Providence Health & Services
- Registration Number
- NCT01416844
- Locations
- 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 44
- Registration Number
- NCT01416831
- Locations
- 🇺🇸
Providence Cancer Center, Portland, Oregon, United States
Prospective Donor Specific Antibody (DSA) Monitoring Protocol
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2011-08-04
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 60
- Registration Number
- NCT01382355
- Locations
- 🇺🇸
Providence Sacred Heart Medical Center, Spokane, Washington, United States
Immunochemoradiotherapy in Patients With Pancreatic Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-04-27
- Last Posted Date
- 2018-04-12
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 11
- Registration Number
- NCT01342224
- Locations
- 🇺🇸
Providence Health & Services, Portland, Oregon, United States
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-02-25
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 13
- Registration Number
- NCT01303705
- Locations
- 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-01-27
- Last Posted Date
- 2015-09-07
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 6
- Registration Number
- NCT01057212
- Locations
- 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
Work Hour Reductions, Medical Errors, and Intern Well-Being at Providence St. Vincent Medical Center Intensive Care Unit
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-10-16
- Last Posted Date
- 2009-10-16
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 22
- Registration Number
- NCT00996320
- Locations
- 🇺🇸
Providence St. Vincent Medical Center Intensive Care Unit, Portland, Oregon, United States
© Copyright 2024. All Rights Reserved by MedPath